BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15233223)

  • 1. The role of somatostatin analogs in the management of immunoproliferative disease.
    Ferone D; Arvigo M; Semino C; Pivonello R; van Hagen PM; Barreca A; Minuto F
    J Endocrinol Invest; 2003; 26(8 Suppl):103-8. PubMed ID: 15233223
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of somatostatin analogs in the management of rare tumors and diseases.
    Palmieri G; Montella L
    J Endocrinol Invest; 2003; 26(8 Suppl):89-91. PubMed ID: 15233221
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale for treating cancer with somatostatin analogs.
    Minuto F; Ferone D; Arvigo M; Barreca A
    J Endocrinol Invest; 2003; 26(8 Suppl):117-9. PubMed ID: 15233226
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of somatostatin analogs in the management of prostate cancer.
    Sinisi AA; Rossi V; Prezioso D; Notaro A; Bellastella G; Panza N; Bellastella A; Pasquali D
    J Endocrinol Invest; 2003; 26(8 Suppl):120-4. PubMed ID: 15233227
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin receptors and breast cancer.
    Cameron Smith M; Orlando C; Serio M; Maggi M
    J Endocrinol Invest; 2003; 26(8 Suppl):125-30. PubMed ID: 15233228
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor effects of somatostatin.
    Pyronnet S; Bousquet C; Najib S; Azar R; Laklai H; Susini C
    Mol Cell Endocrinol; 2008 May; 286(1-2):230-7. PubMed ID: 18359151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Somatostatin receptors in immune system cells].
    Ferone D; Lombardi G; Colao A
    Minerva Endocrinol; 2001 Sep; 26(3):165-73. PubMed ID: 11753240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
    Janson ET; Oberg K
    Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
    [No Abstract]   [Full Text] [Related]  

  • 9. Somatostatin and somatostatin receptors in Cushing's disease.
    Hofland LJ
    Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors.
    Pivonello R; Ferone D; Filippella M; Faggiano A; De Martino MC; Auriemma RS; Rota F; Lombardi G; Colao A
    J Endocrinol Invest; 2003; 26(8 Suppl):82-8. PubMed ID: 15233220
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of somatostatin analogs in the management of hepatocellular carcinoma.
    D'Agostino L; Manguso F; Pivonello R; Colao A
    J Endocrinol Invest; 2003; 26(8 Suppl):131-3. PubMed ID: 15233229
    [No Abstract]   [Full Text] [Related]  

  • 12. Conclusions: the future role of somatostatin analogs.
    Lamberts SW
    J Endocrinol Invest; 2003; 26(8 Suppl):134-5. PubMed ID: 15233230
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
    Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
    J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Somatostatin receptors and its analogs in diagnosis and treatment of human tumors].
    Raĭkhlin NT; Smirnova EA; Delektroskaia VV
    Vopr Onkol; 2010; 56(1):7-13. PubMed ID: 20361608
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatostatin, its receptors and analogs, in lung cancer.
    O'Byrne KJ; Schally AV; Thomas A; Carney DN; Steward WP
    Chemotherapy; 2001; 47 Suppl 2():78-108. PubMed ID: 11275704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of somatostatin in breast cancer.
    Watt HL; Kharmate G; Kumar U
    Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Somatostatin, somatostatin analogs and their clinical use].
    Krsek M
    Cas Lek Cesk; 2003 Mar; 142(3):134-8; discussion 139. PubMed ID: 12756839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors.
    Kvols LK; Woltering EA
    Anticancer Drugs; 2006 Jul; 17(6):601-8. PubMed ID: 16917205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of breast cancer: is there a role for somatostatin and its analogs?
    Boccardo F; Amoroso D
    Chemotherapy; 2001; 47 Suppl 2():62-77. PubMed ID: 11275703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro testing of new somatostatin analogs on pituitary tumor cells.
    Zatelli MC; Ambrosio MR; Bondanelli M; degli Uberti EC
    Mol Cell Endocrinol; 2008 May; 286(1-2):187-91. PubMed ID: 18243520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.